GasGasGas – The FRCA Primary Anaesthetics Exam Podcast

Bupivacaine for the FRCA Primary
In this episode, we dive deep into bupivacaine, exploring its friends (additives), mechanisms of action, and clinical applications. We'll also cover the key differences between neuronal and cardiac action potentials, and discuss why levobupivacaine has become the preferred choice in many clinical scenarios.
The Local Anaesthetics Chapter:
Bupivacaine Classification
- Name: Bupivacaine
- Class: Amide Local Anaesthetic
- Molecular Weight: 288.43 g/mol
Appearance & Preparations
- Clear, colourless solution containing racemic mixture of R and S enantiomers
- Standard concentrations: 0.25%, 0.5%, sometimes 0.75%
- With adrenaline: 1 in 200,000 solution (improves surgical field, not block duration)
- Hyperbaric (Heavy): Mixed with 80mg/ml glucose for intrathecal use
Pharmacodynamics of Bupivacaine
Mechanism of Action of Bupivacaine
Sodium Channel Blockade
Local anaesthetics work through voltage-gated sodium channel blockade. The process involves:
- Unionised fraction crosses nerve membrane
- Re-equilibration occurs inside the nerve
- Ionised fraction blocks sodium channels
- Use-dependent block - higher affinity for open channels
Key Factors Affecting Action of Bupivacaine
- pKa influences onset: Lower pKa = more unionised fraction = faster onset
- Lipid solubility: Affects tissue penetration
- Protein binding: Higher binding = longer duration
Bupivacaine Specifics
- pKa: 8.1 (15% unionised at physiological pH)
- Protein binding: 95% (mainly to alpha-1 acid glycoprotein) but also albumin binding
- Highly lipophilic
Action Potentials Compared
Neuronal Action Potential (4 Phases
- Phase 1: Initial sodium channel opening
- Phase 2: Depolarisation - widespread Na+ channel opening at -55mV threshold
- Phase 3: Repolarisation - Na+ channels close, K+ channels open
- Phase 4: Hyperpolarisation - overshoot before returning to resting potential
Key Difference: No plateau phase, rapid up-and-down pattern
Cardiac Action Potential (5 Phases)
- Phase 0: Initial depolarisation (Na+ in, K+ out). (WHERE BUPIVACAINE CAUSES SLOWER UP SLOPE)
- Phase 1: Brief rebound repolarisation (+52mV)
- Phase 2: Plateau phase - L-type Ca2+ channels open (unique to cardiac muscle)
- Phase 3: Repolarisation - Ca2+ channels close, K+ channels open
- Phase 4: Resting state (-96mV)
Key Difference: Plateau phase due to calcium influx - critical for sustained cardiac contraction
Clinical Uses of Bupivacaine
- Post-operative pain control (TAP blocks, wound infiltration and all the regional varieties that you may do pre as well as post op)
- Intra-operative anaesthesia (spinal, epidural)
- Regional blockade (limb blocks, trauma pain relief)
- Neuraxial anaesthesia (labour epidurals, caesarean sections)
Dosing Guidelines
Route | Maximum Dose | Notes |
---|---|---|
Intrathecal | Up to 15mg (3ml of 0.5%) | Higher doses used for bilateral surgery in US |
Epidural | 2mg/kg | Dilute infusions (0.1%) for motor-sparing blocks, especially levobupivacaine |
Infiltration | 2mg/kg | Wound infiltration, rectus sheath blocks |
Regional | 2mg/kg | Brachial plexus, peripheral nerve blocks |
Onset time: 10-20 minutes (warn patients!) Duration: 5-16 hours
The Mixing Dilemma
Why Lidocaine + Bupivacaine Doesn't Work
Many attempt to mix fast-acting lidocaine with long-acting bupivacaine, but this fails on two counts:
- Dilution effect: 1ml 2% lidocaine + 1ml 0.5% bupivacaine = 2ml of 1% lidocaine + 0.25% bupivacaine
- pH incompatibility: Lidocaine's acidic pH shifts environment away from bupivacaine's preferred alkaline conditions
Bottom line: Don't mix them!
Successful Additives for Bupivacaine
Additive | Compatibility | Effect | Evidence |
---|---|---|---|
Bicarbonate | ❌ Precipitates with bupivacaine | 'would' cause Faster onset | Use with lidocaine only |
Clonidine | ✅ Compatible | May prolong block | Mixed evidence |
Dexmedetomidine | ⚠️ Technically incompatible | Extends duration | Some positive studies |
Steroids | ✅ Good evidence | Prolongs effect | IV route may be equally effective |
Ketamine | ⚠️ Potential neurotoxicity | Some analgesia benefit | Concerns about nerve damage |
Side Effects & Toxicity of Bupivacaine
Cardiovascular Toxicity - Bupivacaine has particular affinity for cardiac tissues:
- Blocks cardiac sodium channels (impairs phase 0)
- Reduces peripheral vascular resistance
- Decreases myocardial contractility
- Highly arrhythmogenic
- Prolongs PR, QRS intervals and QT
CNS Toxicity of Bupivacaine
Progressive symptoms based on plasma concentration:
- Early: Tinnitus, metallic taste, circumoral tingling
- Moderate: Sensory disturbances, excitation/agitation
- Severe: Seizures, coma, respiratory depression
Toxic Dose of Bupivacaine
>2mg/kg Ideal Body Weight - but this is infiltrative safe dose, NOT intravenous safe dose!
Pharmacokinetics of Bupivacaine
Absorption
Varies dramatically by injection site - in most to least absorbed: Intercostal > Caudal >Epidural > Brachial plexus > Subcutaneous
Note: Vasoconstrictors don't significantly help with bupivacaine due to its inherent vasodilatory effect.
Distribution & Elimination
- Volume of distribution: 21-103 litres
- Clearance: 0.47 L/min
- Elimination half-life: 20-40 minutes (IV)
- Metabolism: Hepatic N-dealkylation to inactive pipecoloxylide
Levobupivacaine (Chirocaine)
Why the S-Enantiomer?
Levobupivacaine is the S-enantiomer of the racemic bupivacaine mixture, offering several advantages:
Key Differences
- Reduced cardiotoxicity - the major selling point
- Less motor block at low concentrations
- Preferential sensory blockade
- Slightly less potent than racemic mixture
Dosing
- Maximum single dose: 150mg
- 24-hour maximum: 400mg
- Weight-based: Some Folk go to 2.5mg/kg (vs 2mg/kg for standard bupivacaine)
- in the exam, stick with 2mg/kg as it is safe to say so.
Clinical Preference
The reduced cardiotoxicity makes levobupivacaine the preferred choice - CNS toxicity (generally temporary) is more manageable than cardiac toxicity (potentially fatal).
Key Takeaways for Bupivacaine Know how
- Bupivacaine is highly cardiotoxic - respect the dosing limits
- Don't mix with lidocaine - it doesn't work as intended
- Warn patients about onset time - 10-20 minutes to avoid looking "daft"
- Levobupivacaine is safer - less cardiotoxic, preferred choice
- Understand action potentials - cardiac has plateau phase, neuronal doesn't
- Additives have mixed evidence - steroids show most promise
Cross-References to Other Gas, Gas, Gas Episodes
- Local Anaesthetics Introduction- An excellent primer!
- Episode 2 - Propofol - Understanding pKa and pharmacokinetic principles
- TIVA Models for Propofol - Polycompartmental models referenced in this episode
- Episode 7 - Compartmentalised Volatiles - Compartmental thinking for drug kinetics
- Rocuronium Episode - First episode covering drug classification approach
Essential References
Primary Literature
- Nestor et al. "Pharmacological and clinical implications of local anaesthetic mixtures: a narrative review." Anaesthesia 2022. DOI: 10.1111/anae.15641 - The definitive review on why mixing local anaesthetics doesn't work
- Christie et al. "Local anaesthetic systemic toxicity." BJA Education 2015. DOI: 10.1093/bjaceaccp/mku027 - Comprehensive LAST review
Cardiotoxicity & Levobupivacaine
- Bardsley et al. "A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine." British Journal of Anaesthesia 2001. PMC1873676 - Human volunteer study showing reduced cardiotoxicity
- Morrison et al. "Electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine." Anesthesia & Analgesia 2000. PMID: 10825312 - Animal model comparing cardiotoxicity
- Whiteside & Wildsmith. "Developments in local anaesthetic drugs." BJA 2001. DOI: 10.1093/bja/87.1.27 - Historical development of safer local anaesthetics
Guidelines & Safety
- AAGBI Safety Guideline: "Management of Severe Local Anaesthetic Toxicity" 2010. Available online - Essential emergency management
- Local anaesthetic systemic toxicity: Current perspectives. PMC 2018. PMC6087022 - Modern understanding of LAST mechanisms
Pediatric Considerations
- Chalkiadis et al. "Pharmacokinetics of levobupivacaine 0.25% following caudal administration in children." BJA2004. DOI: 10.1093/bja/aeh017 - Important pediatric dosing considerations
Pivotal Mallard Duck Paper
- Brenner DJ, Larsen RS, Dickinson PJ, Wack RF, Williams DC, Pascoe PJ. Development of an avian brachial plexus nerve block technique for perioperative analgesia in mallard ducks (Anas platyrhynchos). J Avian Med Surg. 2010 Mar;24(1):24-34. doi: 10.1647/1082-6742-24.1.24. PMID: 20496603.
Support the Show
If you found this episode helpful:
- Leave a review on your podcast platform
- Share with colleagues
- Consider supporting via PayPal
Remember: Every day you are getting better at this! Take it day by day, don't overcook yourself, and keep studying.
Episode length: ~24 minutes Release: Gas, Gas, Gas Podcast Host: James
"Thanks for listening guys... Every day you are getting better at this. Take it day by day, don't overcook yourself, don't freak out, and keep studying!"
Podcast Information & Support
Support the Show
Contact & Feedback
- Comments: Share your clinical experiences and ask questions!
- Corrections: Help us improve accuracy and clarity
Follow GasGasGas On
- BlueSky:Gas Gas Gas (@gasgasgaspodcast.bsky.social)
- X / Twitter: GasGasGasFRCA (@GasGasGasFRCA) / X
- FaceBook: Facebook - Gas Gas Gas
- InstaGram: GasGasGas
Transcript
Episode 31: Bupivacaine and Friends - Consolidated Transcript
Introduction and Welcome
00:00-01:25
Please listen carefully and let's get on with the show. Hi everyone, this is James at Gas, Gas, Gas. Today we are getting stuck into bupivacaine, thinking about friends that you might mix with bupivacaine, going to touch on action potentials in cardiac and neuronal tissues, break down all the additives that you might want to introduce alongside your local anaesthetic agent, and then touch on levobupivacaine, why it's different, why we seem to like it.
Since the last episode, I have managed to set up a donation system that's using PayPal. If you think you want to support the show, there's a link in the show notes for it. Any sort of donation is appreciated. Or if you don't fancy that, just leave me a review. Tell me if you like it or not, because that'll keep me going. Because sometimes it does sound and feel like you're sort of shouting into the ether. Although I know the stats for the podcast are always on the upward trend, it always helps to know if I can do anything better. Anyway, on to bupivacaine.
Bupivacaine Overview and Preparations
01:26-02:26
This is a local anaesthetic agent, but it's an amide local anaesthetic agent. We touched on it in the introduction episode. Remember, the other local anaesthetic agent is esters. It's a clear colourless solution, and it contains a racemic mixture of R and S enantiomers of bupivacaine.
Classically, it is provided in concentrations of 0.25% and 0.5% solution, although there are 0.75% preparations as well. There are a number of preparations also combined with adrenaline in a 1 in 200,000 solution, noting that this doesn't improve the length of block, but improves the surgical field for the surgeons, so there's less blood sloshing around. Bupivacaine is also supplied as a hyperbaric mixture, aka heavy bupivacaine, and this is mixed with 80 milligrams per ml of glucose, creating that higher specific gravity that means that we can manipulate how local anaesthetic works in people's CSF spaces. Its molecular weight for those who are deeply excited by such a thing is 288 grams per mole.
Pharmacodynamics and Mechanism of Action
02:38-04:00
Pharmacodynamics of bupivacaine. It works by sodium channel blockade. Let's remember that there are sodium channels in a number of places in the human. We're interested in the sodium channels you will find on neuronal membranes, at least initially. But first, let's think about the details of this mechanism.
We know that the pKa influences onset time because the unionised fraction is the one we're interested in when it comes to drug getting in the right place to work. We also know that its lipid solubility plays a role in this and let's recall that protein binding plays a role in how prolonged the action of the local anaesthetic is. The more protein bound generally the longer it lasts. We need to bear in mind that this unionised fraction gets into the nerve but then it's going to re-dissociate because everything is in a dynamic equilibrium. It's the ionised fraction of the re-dissociated molecule that's got into the nerve that is the one that actually does the sodium channel blockade.
You can imagine that the amount of agent you give, the amount that actually makes it to the effect site is quite a small fraction and we know that this plays out in most drugs we administer to humans. Go back and listen to any of those other episodes if you don't have a clue what I'm on about, maybe start with the polycompartmental model episodes or the TCI propofol episode.
Sodium Channels and States
04:00-05:06
Let's focus back in on local anaesthetics and this sodium channel they act on. This sodium channel, you'll find it in your neuron, generally speaking in those nodes of Ranvier, and it has three states, two natural human-y type states, i.e. open, it's letting sodium in, or closed, it's not letting sodium in, but then also a local anaesthetic bound state, because we know that if you have a protein and then you stick something to that protein, it causes a conformational change to that thing. That's why all these drugs have influences on all these proteins, protein coupled receptors, channels, tyrosine kinase receptors, etc. Something binds to something changing the shape of the thing and altering its activity.
Now interestingly local anaesthetic agents prefer the open state i.e. that open state enables a higher affinity of local anaesthetic to sodium channel. This is called use dependent or phasic block if you want to apply a buzzword to it.
Neuronal Action Potentials (Four Phases)
05:06-06:58
Before I get back into the depths of bupivacaine let's just quickly touch on these neuronal action potential phases because we're going to do it properly in perhaps three and a half decades when we finally get onto physiology. The curriculum is massive, but remember this is something you might be asked to draw in the exam.
For a neuron, i.e. a nerve that is conducting something in your peripheral nervous system, there are four phases and the graph is a graph of a line running at a sort of basal electronegative state with then a rapid upshoot and then a rapid down shoot. There's no middle ground, there's no plateau phase in a nerve action potential.
When your action potential comes along, some voltage-gated sodium channels open, because naturally there has to be a degree of conduction at this point in time. However, once a sufficient number of voltage-gated sodium channels open, you hit a shift in your neuronal electronegativity, deflecting back towards positive, i.e. when you hit about minus 55 millivolts, you trigger widespread voltage-gated channel opening. Loads of sodium pours into the cell. Remember that there's lots of sodium outside of a cell, not much in. There's loads of potassium inside a cell and there's not much out. All that sodium piles in and the neuronal membrane becomes positive.
These sodium channels don't stay open forever. However, once you hit that positive state, voltage-gated potassium channels trigger open, allowing efflux of potassium, triggering a repolarisation of that nerve into the world of electronegativity. Interestingly nerves of the peripheral nervous system overshoot their electronegativity as they repolarise. They dip down a little bit more negative than they otherwise would rest at before returning to that resting negative neuronal potential waiting for a new action potential to flow along. Four phases one two three and four, no plateau.
Clinical Uses of Bupivacaine
07:04-08:03
Back to bupivacaine what do we use bupivacaine for? I'm sure you're all thinking this is daft, but you might get asked it in the exam. It is used for post-operative pain control when you've administered a block at the end of surgery, i.e. you've done a TAP block, or the surgeons have done an iliohypogastric block for an inguinal hernia. You could utilise it for intra-operative pain control. This is the realms of your spinal anaesthetic, or you're thinking you want to actually cover the operative intervention with some form of local anaesthesia, a spinal and GA for example.
And then regional blockade either to facilitate surgery upper limb blocks lower limb blocks or regional blockade following traumatic injury. I think we're ending up using erector spinae plane blocks and serratus anterior blocks and paravertebral blocks much more frequently to provide pain control. You could break this down further into anaesthesia that achieves sensory blockade or sensory and motor blockade because we like to differentiate some limb blocks as motor sparing, which the orthopaedic surgeons love for their knee replacements. But that's more detail than we're going into today.
Dosing Guidelines
08:04-10:01
Dosing, how do we dose bupivacaine? It depends where you're putting it. Because you could, in theory, do two milligrams per kilo intrathecally. That isn't a toxic dose from the perspective of local anaesthetic toxicity, but you would have a total spinal and a very cardiovascularly unstable patient. Generally speaking, most people go up to 15 milligrams of intrathecal bupivacaine, i.e. 3 ml of 0.5%. You can go quite low and sometimes people go a tad higher. I do know, having had a nosy about this for bilateral hip or knee replacements, which they do in some sites in the United States, they put quite a bit more. They're going to do both hips at once. Not something that tends to happen so much in the UK.
Other routes. Remember we have intrathecal, we have epidural, and in this site you can go up to two milligrams per kilo. Infiltration, again two milligrams per kilo. That's injecting your caesarean section incision site at the end of a case or rectus sheath catheters. Topical, I don't really know how much topical bupivacaine anyone's using. If people are, let me know. And intravenous dosing. We don't tend to do that. You can use other local anaesthetics in intravenous manner, lidocaine and prilocaine in Bier's blocks, if I remember correctly. And I did because I've just checked. Can you put it intra-arterially? No, it's going to be just as toxic. It's just going to take slightly longer to work. And what I mean by work is slightly longer to cause a local anaesthetic toxicity disaster. You might get a slightly mixed picture if you were to inject that into carotid because you're going to get CNS symptoms very quickly and then cardiac symptoms a bit later because it's got to go all through the brain and back down.
Onset Time and Duration
10:01-11:03
We've mentioned toxicity quite a few times here. The toxic dose of bupivacaine is two milligrams per kilo. Now is that if you stick two milligrams per kilo into someone's vein you will get away with it? And the answer is no you won't. Two milligrams per kilo is your infiltrative safe dose. Bearing in mind we all know that local anaesthetic uptake differs depending on the site you've injected it in. Mentioned that in the previous episode, you can go back and have a listen. But now we're thinking we've chucked this dose of bupivacaine in around someone's brachial plexus. How long does it take to work? I would generally quote patients 10 to 20 minutes, but sometimes it can be even longer than that. Axillary blocks seem to take ages to work.
Now, if you've sold a regional anaesthetic to a patient with excellent skill, having balanced their risks and benefits and consented them appropriately, but then you forgot to tell them it takes a while, you've stuck that injection in, and then you've started pottering around and doing other things, and then looking at you with raised eyebrows, you've lost your patient a little bit there. Open the door with how long it takes to work, but then, you know, it does last for up to 16 hours, and sometimes a bit longer with additives.
Local Anaesthetic Mixtures and pH Issues
11:03-12:24
You might have seen some folk mixing drugs together. Wouldn't it be dandy if we could use a local anaesthetic that acts really quickly, and then mix it with one that takes longer to work, but lasts longer so that you get the best of both worlds fast acting and lasts a while unfortunately it doesn't quite 100% work like that say we take lidocaine and mix it with bupivacaine seems like a great idea we've taken one ml of two percent lidocaine and we've mixed it with one ml of 0.5 percent bupivacaine what this actually ends up giving you is a two millilitre mixture that is itself one percent lidocaine and 0.25 percent bupivacaine and you're probably thinking right now, well that's not the end of the world is it? And technically no, but there's another complicating factor here in that the pH of lidocaine in its natural form is different to that of bupivacaine. And herein lies an issue.
Now we're going to touch on bupivacaine pKa in a minute, but the pKa is 8.1 and it is 15% unionised, whereas lidocaine 7.7, 25% unionised. However, the pH of lidocaine is more acidic than the pH of the good old-fashioned ampoule of bupivacaine. Actually you create a more acidic environment for the bupivacaine to work. And as we all know, bupivacaine wants to be more alkaline. Therefore, you actually impair the function of your long acting agent. It fails on two counts of physicochemical reality. You just don't do it.
Additives and Bicarbonate
12:24-13:31
Now, there's a great paper that I'm going to link in the show notes that explores pharmacological and clinical implications of local anaesthetic mixtures. And it's a narrative review and it's really good. I would thoroughly recommend reading that. But you might have heard about mixing bicarbonate in with things. You know, you've got that bum abscess, it's grotty, it's angry, it's inflamed, the tissues are acidic around it, the local anaesthetics just barely work. Wouldn't it be dandy if we could make it more alkaline with bicarbonate? And the answer is yes you can. If you mix in bicarbonate you achieve a more alkaline environment and therefore improved onset time.
Again we hit another barrier here though in that unfortunately bupivacaine, levobupivacaine and ropivacaine have a tendency to precipitate when mixed with bicarbonate, so that's kind of in the bin. However, lidocaine behaves and therefore that is an option, mix your lidocaine with bicarbonate. It's approximately 1 ml of 8.4% sodium bicarbonate per 10 ml of local anaesthetic. Some sites use a lidocaine bicarbonate mix for rapid onset of surgical anaesthesia via the epidural route in caesarean sections. You bang it in and it works real quick.
Other Additives
13:31-14:54
There are a number of other additives that are used, were used, could be used more in the future. Noting that you could mix clonidine in, that's compatible with lidocaine and bupivacaine. The evidence is mixed, but it may improve block duration. And again, dexmedetomidine, this is technically not compatible, but seemingly folks do use it. And that appears to extend block effect in some studies far. Ketamine has been used, and it has a positive effect. Ketamine in itself has some local anaesthetic-like sodium channel blocking properties. However, there is some evidence that it is injurious to those nerves and the CNS.
There's a degree of evidence that says that magnesium prolongs regional anaesthetic blockade. You just need to make sure you don't accidentally put a humongous amount intrathecally. Apparently that's happened. Steroids. There's mounting evidence that either co-administered steroids or IV high-dose steroids prolongs the effect of your local anaesthetic on nerve, although it may actually be that intravenous steroids work just as well. With a lower risk factor, you're putting less next to very important nerve structures. Now, we know that opioids seem to improve the quality of neuraxial anaesthesia. I don't know about regional anaesthesia and if you stick some fentanyl in someone's interscalene, whether or not that has any value. Obviously, these nerves have opiate receptors, but I wonder if anyone knows that, please drop me an email.
Side Effects and Toxicity
15:01-16:32
We've dipped quite deep into pharmacodynamics there before we've even got to side effects. These drugs do have a side effect profile, chiefly ones arising from toxicity, we know they're toxic. Bupivacaine tends to favour the cardiovascular system, binding to myocardial proteins and blocking cardiac sodium channels. This impairs the phase zero of the cardiac action potential, and we're going to touch on that in a second, but also can drop your peripheral vascular resistance or your systemic vascular resistance, as well as dropping your contractility and being arrhythmogenic.
From a neuro perspective, we have sodium channels in our brains, unsurprisingly, everyone. You get a spectrum of effect here depending on how much agent has been absorbed and delivered to the brain. These could come on very quickly if you've accidentally squirted some into a vein and over a prolonged period of time if you've inadvertently overdosed someone in a highly vascular bit of tissue. Early signs, patients get some slightly excitatory effects. They get sensory disturbances like tinnitus, altered taste sensation, metallic taste in mouth, circumoral tingling. They can then progress on to seizure activity and coma. Now you could perhaps make an argument that if someone's in a coma due to local anaesthetics, then maybe they're going to not breathe very much. It's not really quite a side effect in some ways. And as I understand, there are no real quoted GI, renal, metabolic or endocrine side effects of local anaesthetics that you're going to be asked about in the exam. It's all about the toxicity.
Cardiac Action Potentials (Five Phases)
16:32-18:53
And we touched on the action potentials of nerves. I just want to quickly differentiate the action potentials you see in myocardium because this is something that interminably flummoxed me because it all sounds exactly the same and it's probably going to sound exactly the same to you but consider it cognitive priming. There are actually five phases of the cardiac action potential compared to a standard nerve with four. You have a phase zero and then a one, two, three and a four.
Now phase zero is the initial depolarisation, that uptick. You get sodium shifting in and potassium being able to shift out. There's phase one and this is a very small uptick at the top of this. If you imagine that initial depolarisation phase almost overshoots slightly. Phase one happens and there's a slight rebound repolarisation, i.e. a drop in the positivity of that cell, only slightly, and this is due to briefly opened potassium channels, letting some potassium out.
Then you have phase two. This is the phase that you don't see in other neuronal action potentials, and it is the plateau phase. This is facilitated by calcium channels, and these are L-type calcium channels. I don't know if the L stands for long, but they open, they let calcium into the cell. This calcium was obviously quite useful for sarcoplasmic reticulum to contract, but calcium influx provides a prolonged period of positive cell membrane compared to good old-fashioned nerve.
Phase three is our dip back towards electronegativity. Phase three is repolarisation. Calcium channels that have been open close. Potassium channels wide open here, allowing shift of potassium out of the cell, dropping it back towards electronegativity. And we get phase four, this is the resting state, which is confusing really, because I would say that the resting state should be like first thing but who knows anyway phase four resting state negative 90 millivolts and this is facilitated by those potassium channels being open and a loss of whatever sodium and calcium channels remain trying to be open they're gone five phases 0 1 2 3 4 2 is the plateau phase that's where you're getting all that calcium ingress courtesy of our L-type calcium channels let's remember that these L-type calcium channels are a drug target, folks. That's where your dihydropyridines and non-dihydropyridines come into play.
Pharmacokinetics
19:00-21:24
Right, quite a bit of talking thus far, but let's just touch on the pharmacokinetics of these drugs. Remember, pharmacokinetics is absorption, distribution, metabolism, and elimination. I mentioned earlier that the absorption behaviour of bupivacaine depends on where it is injected and the vascularity of that site. The range from most absorption to least absorption, we say intercostal most, then caudal, then epidural, and then brachial plexus, and then subcutaneous administration. There is a linear dose response relationship between peak plasma concentration you will see and the amount of drug you've put in.
Vasoconstrictors in the world of bupivacaine do not influence this terribly much because bupivacaine has a local vasodilatory effect, which is bothersome. It's probably that the surgeons stick adrenaline in to make themselves feel better and actually it probably doesn't change very much. This bears out in reality because we know it doesn't change how long the drug lasts for because the bupivacaine causes dilation which means there's clearance from that site. That same dilation is not altered by administering adrenaline. The time it lasts is the same therefore who really knows. But if it makes them happy it doesn't matter although you might see a little bit of that beta-1 beta-2 response that you get by administering adrenaline into subcutaneous tissues and you might get a bit of hypertension and then hypotension, very interesting.
Distribution. Its pKa as mentioned above is 8.1. At physiological pH you have 15% unionised. It is 95% protein bound which is mega and in plasma it is mostly bound to alpha-1 acid glycoprotein. It has a volume of distribution of 21 to 103 litres but I don't really think it is terribly relevant for this drug and it also binds to albumin.
Metabolism. How does the body get rid of it? Bupivacaine undergoes N-dealkylation, remember that's a phase one metabolism liver thing, into pipecoloxylidide. I don't think you need to know that, but it is inactive. It gets through the liver, phase one metabolism, N-dealkylation, inactive metabolite. Clearance of 0.47 litres per minute and the elimination half-life after intravenous administration is 0.3 to 0.6 hours, i.e. 20 to 40 minutes. It does get out reasonably quickly.
Allergies and Interesting Facts
21:24-22:08
Other things of note, remember that patients can be allergic to local anaesthetic agents, although classically more likely to be allergic to ester local anaesthetic agents than amide local anaesthetic agents. And interestingly, some vets administered up to 8 milligrams per kilo of bupivacaine when they were trying to do interscalene blocks on ducks, and none of the ducks died. However, we need to think that maybe it's quite hard to inject into the brachial plexus of a mallard duck. And maybe if they're squirting bupivacaine into a tendon or other fairly avascular structures, the odds are that it couldn't absorb quick enough to cause harm. Not that I'm recommending that as a dose, but I thought that was an interesting aside and reflects how easy it is to get very lost on the internet reading about things.
Levobupivacaine (Chirocaine)
22:10-24:04
Just to close out the show, guys, and I hope you've managed to get here thus far, levobupivacaine, otherwise known as chirocaine, and chiro because it's all about chiral molecules and enantiomers, which we're going to touch on later. Levobupivacaine is the S enantiomer of the racemic bupivacaine mixture. Why are we interested in levobupivacaine? Well, it does seem to cause a bit less of a motor block, interestingly. It seems to yield sensory blocks more, especially in lower doses. There is a notion that it is slightly less potent than its racemic mixture which might make you think that if you were to take the other enantiomer R-bupivacaine you might have a more potent local anaesthetic agent.
Why on earth did they bother trying to divvy this out and use one half of bupivacaine? And the answer is levobupivacaine is less cardiotoxic. If you were to pick which toxicity you would like, CNS toxicity, i.e. your brain turns off until you clear the local anaesthetic out, is probably less harmful than ventricular fibrillation. One, you just need to wait. The other one, you might not be able to undo. Hence why levobupivacaine is more readily favoured.
What is the dose? The max dose is generally quoted as 150 milligrams in one go with a total of 400 milligrams over 24 hours. This would work out at about 30 ml of 0.5% in an appropriately sized adult or about 200 ml of 0.5% over 24 hours. In some literature, the max dose of levobupivacaine is quoted as 2.5 milligrams per kilo instead of the 2 milligrams per kilo of standard bupivacaine. This is why it tends to be favoured. It really confused me when I first started. Which one's levo? Which one's bupivacaine? Which one's chirocaine? Which one's marcaine? Chirocaine is levobupivacaine. Standard bupivacaine is marcaine. Heavy marcaine is when it's mixed with glucose for intrathecal administration so it sinks down.
Closing Remarks
24:04-24:57
And that's your lot folks, you've listened to the end, you've done brilliantly well. That was bupivacaine with a touch on cardiac action potential, neuronal action potential and additives you could mix in and their approximate likelihood of having clinical benefit. I think the jury is approximately out on most of it, there's no robust consistent, everyone does one thing, I think I'd be tempted to say that steroids probably help and most other things might help but it's less clear at this point in time.
Thanks for listening guys, I hope you've found it useful but if you found it awful do let me know. Please like and subscribe, register with whichever podcast platform you find yourself using and leave a comment if you think I need to square something away. I just want to make sure that you guys know that every day you are getting better at this. There is a bucket of content to try and consume and it is like drinking from a fire hose. Take it day by day, don't overcook yourself, don't freak out and keep studying.
This is the full un modified Show Transcript - Courtesy of Whisper LLM
00:00-00:00
Please listen carefully.
00:30-00:31
and let's get on with the show.
00:35-00:37
Hi everyone, this is James at Gas, Gas, Gas.
00:38-00:40
Today we are getting stuck into bupivacaine,
00:41-00:44
thinking about friends that you might mix with bupivacaine,
00:44-00:48
going to touch on action potentials in cardiac and neuronal tissues,
00:49-00:52
break down all the additives that you might want to introduce
00:52-00:52
alongside
00:52-00:53
your
00:53-00:54
local anaesthetic agent,
00:54-00:58
and then touch on Levo bupivacaine, why it's different, why we seem to like it.
00:58-01:02
Since the last episode, I have managed to set up a donation system that's using PayPal.
01:03-01:05
If you think you want to support the show, there's a link in the show notes for it.
01:06-01:07
Any sort of donation is appreciated.
01:08-01:10
Or if you don't fancy that, just leave me a review.
01:10-01:13
Tell me if you like it or not, because that'll keep me going.
01:13-01:17
Because sometimes it does sound and feel like you're sort of shouting into the ether.
01:17-01:21
Although I know the stats for the podcast are always on the upward trend.
01:21-01:23
It always helps to know if I can do
01:23-01:23
anything better.
01:24-01:24
Anyway,
01:24-01:26
on to bupivocaine.
01:26-01:30
So this is a local anaesthetic agent, but it's an amide local anaesthetic agent.
01:31-01:32
We touched on it in the introduction episode.
01:32-01:35
Remember, the other local anaesthetic agent is esters.
01:35-01:38
So it's colour, its appearance, how you might want to introduce it.
01:38-01:47
So it's a clear colourless solution, and it contains a racemic mixture of R and S enantiomers of bupivacaine.
01:47-01:55
Classically, it is provided in concentrations of 0.25% and 0.5% solution, although there are 0.75% preparations as well.
01:55-02:00
There are a number of preparations also combined with adrenaline in a 1 in 200,000 solution,
02:00-02:06
noting guys that this doesn't improve the length of block, but improves the surgical field for the
02:06-02:12
surgeons, so there's less blood sloshing around. Bupivacaine is also supplied as a hyperbaric
02:12-02:18
mixture, aka heavy bupivacaine, and this is mixed with 80 milligrams per mil of glucose,
02:19-02:24
creating that higher specific gravity that means that we can manipulate how local anesthetic works
02:24-02:26
in people's CSF spaces. Cool. It's a
02:26-02:27
molecular weight for
02:27-02:29
those who are deeply excited by such
02:29-02:38
a thing is 288 grams per mole. So pharmacodynamics of bupificane. So it works by sodium channel
02:38-02:42
blockade. Let's remember that there's sodium channels in a number of places in the human.
02:42-02:47
We're interested in the sodium channels you will find on neuronal membranes, at least initially.
02:48-02:53
But first, let's think about the details of this mechanism. So we know that the PKA influences
02:53-03:00
onset time because the unionised fraction is the one we're interested in when it comes to drug
03:00-03:01
getting in the right place to
03:01-03:01
work.
03:01-03:05
We also know that its lipid solubility plays a role in this
03:05-03:10
and let's recall that protein binding plays a role in how prolonged the action of the local
03:10-03:16
anaesthetic is. The more protein bound generally the longer it lasts. We need to bear in mind that
03:16-03:21
this unionised fraction gets into the nerve but then it's going to re-dissociate because everything
03:21-03:28
is in a dynamic equilibrium isn't it? It's the ionized fraction of the re-disassociated molecule
03:28-03:33
that's got into the nerve that is the one that actually does the sodium channel blockade. So
03:33-03:39
you can imagine that the amount of agent you give, the amount that actually makes it to the effect
03:40-03:45
site is quite a small fraction and we know that this plays out in most drugs we administer to
03:45-03:50
humans. Go back and listen to any of those other episodes if you don't have a scuba do what I'm on
03:50-03:56
about, maybe start with the polycompartmental model episodes or the TCI propofol episode.
03:56-04:00
So let's focus back in on local anesthetics and this sodium
04:00-04:00
channel they
04:00-04:02
act on. So this sodium
04:02-04:07
channel, you'll find it in your neuron, generally speaking in those nodes of Ranvier, and it has
04:07-04:15
three states, two natural human-y type states, i.e. open, it's litting sodium in, or closed,
04:15-04:21
It's not letting sodium in, but then also a local anesthetic bound state, because we know that if
04:21-04:27
you have a protein and then you stick something to that protein, it causes a conformational change
04:27-04:32
to that thing. That's why all these drugs have influences on all these proteins,
04:33-04:39
protein coupled receptors, channels, tyrosine kinase receptors, etc, etc, etc. Something binds
04:39-04:45
to something changing the shape of the thing and altering its activity. Now interestingly
04:45-04:46
local
04:46-04:53
anaesthetic agents prefer the open state i.e. that open state enables a higher affinity of local
04:54-05:00
anaesthetic to sodium channel. This is called use dependent or phasic block if you want to apply a
05:01-05:06
buzzword to it. So before I get back into the depths of bupivacaine let's just quickly touch
05:06-05:11
on these neuronal action potential phases because we're going to do it properly in perhaps three and
05:11-05:16
a half decades when we finally get onto physiology. The curriculum is massive, but remember this is
05:16-05:22
something you might be asked to draw in the exam. So for a neuron, i.e. a nerve that is conducting
05:23-05:23
something
05:23-05:23
in your peripheral
05:23-05:29
nervous system, there are four phases and the graph is a graph of a line
05:29-05:34
running at a sort of basal electronegative state with then a rapid upshoot and then a rapid
05:34-05:41
down shoot. There's no middle ground, there's no plateau phase in a nerve action potential. So when
05:41-05:46
your action potential comes along, some volt-gated sodium channels open, because naturally there has
05:46-05:46
to
05:46-05:47
be a degree of conduction
05:47-05:51
at this point in time, doesn't there? However, once a sufficient number of
05:51-05:57
volt-gated sodium channels open, that you hit a shift in your neuronal electronegativity, deflecting
05:57-05:58
back towards positive,
05:59-05:59
i.e.
05:59-06:04
when you hit about minus 55 millivolts, you trigger widespread volt-gated
06:04-06:09
channel opening. So loads of sodium pours into the cell. Remember that there's lots of sodium
06:09-06:15
outside of a cell, not much in. There's loads of potassium inside a cell and there's not much out.
06:15-06:16
So all that
06:16-06:16
sodium piles
06:16-06:21
on in and the neuronal membrane becomes positive. These sodium channels
06:21-06:27
don't stay open forever. However, once you hit that positive state, vault gated potassium channels
06:27-06:34
trigger open, allowing efflux of potassium, triggering a repolarization of that
06:34-06:34
nerve
06:34-06:41
into the world of electronegativity. Interestingly nerves of the peripheral nervous system type
06:41-06:46
flavour overshoot their electronegativity as they repolarise. So they dip down a little bit more
06:46-06:48
negative than they otherwise would rest at
06:48-06:50
before returning to that resting
06:50-06:51
negative neuronal
06:52-06:55
potential waiting for a new action potential to flow
06:55-06:55
along.
06:55-06:57
Four phases one two three and four
06:58-07:04
no plateau. So back to bupivacaine what do we use bupivacaine for? So I'm sure you're all kind of
07:04-07:08
thinking this is daft, but you might get asked it in the exam. So it is used for post-operative
07:08-07:13
pain control when you've administered a block at the end of surgery, i.e. you've done a tap block,
07:14-07:14
or the
07:14-07:17
surgeons have done an ilio-inguinal block for an inguinal
07:17-07:17
hernia.
07:17-07:19
You could utilize it for
07:19-07:24
intra-operative pain control. So this is the realms of your spinal anesthetic, or you're thinking you
07:24-07:30
want to actually cover the operative intervention with some form of local anesthesia, a spinal and
07:30-07:30
GA for
07:30-07:35
example. And then regional blockade either to facilitate surgery upper limb blocks lower limb
07:35-07:35
blocks
07:35-07:36
or regional
07:36-07:40
blockade following traumatic injury. So I think we're ending up using erector
07:41-07:47
spinate plane blocks and serratus anterior blocks and paravertibles much more frequently to provide
07:47-07:53
pain control. You could break this down further into anaesthesia that achieves sensory blockade
07:53-08:00
or sensory and motor blockade because we like to differentiate some limb blocks as motor sparing,
08:00-08:02
which the orthopods love for their knee replacements.
08:03-08:03
But that's more detail
08:03-08:04
than we're
08:04-08:08
going into today. So dosing, how do we dose bupivacaine? So it depends where you're putting
08:08-08:11
it, doesn't it? Because you could, in theory, do two milligrams per kilo
08:11-08:12
intrathecally.
08:13-08:13
That isn't
08:13-08:18
a toxic dose from the perspective of local anesthetic toxicity, but you would have a total
08:18-08:19
spinal and
08:19-08:26
a very cardiovascularly unstable patient. Generally speaking, most people go up to
08:26-08:34
15 milligrams of intrathecal bupivacaine, i.e. 3 mils of 0.5. You can go quite low and sometimes
08:34-08:40
people go a tad higher. I do know, having had a nosy about this for bilateral hip or knee
08:40-08:48
replacements, which they do in some sites in the United States, they put quite a bit more. They
08:48-08:52
they're going to do both hips at once. Not something that tends to happen so much in the
08:52-08:53
UK.
08:53-08:58
So other routes. Remember we have intrathecal, we have epidural, and in this site you can go up to
08:58-09:04
two milligrams per kilo. Infiltration, again two milligrams per kilo. That's injecting your
09:05-09:11
cesarean section incision site at the end of a case or rectus sheath catheters. Topical, I don't
09:11-09:13
really know how much topical bupipicane
09:13-09:15
anyone's using. If people are, let me know.
09:15-09:16
And intravenous
09:16-09:22
dosing. We don't tend to do that. You can use other local anaesthetics in intravenous manner,
09:22-09:27
lidocaine and prilocaine in beer's blocks, if I remember correctly. And I did because I've just
09:27-09:33
checked. Can you put it intra-arterially? No, it's going to be just as toxic. It's just going to take
09:33-09:38
slightly longer to work. And what I mean by work is slightly longer to cause a local anaesthetic
09:39-09:45
toxicity disaster. You might get a slightly mixed picture if you were to inject that into carotid
09:45-09:48
because you're going to get CNS symptoms very quickly and
09:48-09:49
then cardiac
09:49-09:50
symptoms a bit later
09:50-09:56
because it's got to go all through the brain and back down. So we've mentioned toxicity hard quite
09:56-10:00
a few times here. The toxic dose of bupivocaine is two milligrams per
10:00-10:01
kilo.
10:01-10:02
Now is that if you
10:03-10:08
stick two milligrams per kilo into someone's vein you will get away with it? And the answer is no
10:08-10:14
you won't. So two milligrams per kilo is your infiltrative safe dose. Bearing in mind we all
10:14-10:20
know that local anaesthetic uptake differs depending on the site you've injected it in.
10:20-10:23
Mentioned that in the previous episode, you can go back and have a listen. But now we're thinking
10:24-10:28
we've chucked this dose of bupivacaine in around someone's brachial plexus. How long does it take
10:28-10:32
to work? I would generally quote patients 10 to 20 minutes, but sometimes it can
10:32-10:33
be even longer
10:33-10:34
than that.
10:34-10:36
Auxiliary blocks seem to take ages to cook.
10:37-10:37
Now, if you've
10:37-10:39
sold a regional anaesthetic
10:39-10:44
to a patient with excellent skill, having balanced their risks and benefits and consented them
10:44-10:44
appropriately,
10:45-10:48
but then you forgot to tell them it takes a while, you've stuck that injection in,
10:48-10:51
and then you've started pottering around and doing other things, and then looking at you with raised
10:52-10:56
eyebrows, you've lost your patient a little bit there. So open the door with how long it takes to
10:56-10:56
work,
10:57-10:58
but then, you know,
10:58-11:02
it does last for up to 16 hours, and sometimes a bit longer with additives.
11:02-11:03
So you might
11:03-11:09
have seen some folk mixing drugs together. Wouldn't it be dandy if we could use a
11:09-11:13
local anesthetic that acts really quickly, and then mix it with one that takes longer to work,
11:13-11:17
but lasts longer so that you get the best of both worlds fast fast acting and lasts a while
11:18-11:22
unfortunately it doesn't quite 100% work like that so say we take lidocaine and mix it with
11:22-11:27
bupivacaine seems like a great idea we've taken one mil of two percent lidocaine and we've mixed
11:27-11:33
it with one mil of 0.5 percent bupivacaine what this actually ends up giving you is a two milliliter
11:34-11:35
mixture that is itself
11:35-11:36
one percent
11:36-11:40
lidocaine and 0.25 percent bupivacaine and you probably
11:40-11:43
at Salen thinking right now, well that's not the end of the world is it? And technically no, but
11:43-11:44
there's another complicating
11:44-11:45
factor here in
11:45-11:49
that the pH of lidocaine in its natural form is different
11:50-11:55
to that of bupivacaine. And herein lies an issue. Now we're going to touch on bupivacaine pKa in a
11:55-12:03
minute, but the pKa is 8.1 and it is 15% unionized, whereas lidocaine 7.7, 25% unionized. However,
12:03-12:08
the pH of lidocaine is more acidic than the pH of the good old-fashioned ampoule of bupivacaine.
12:09-12:13
So actually you create a more acidic environment for the bupificane to work.
12:13-12:17
And as we all know, bupificane wants to be more alkali.
12:17-12:20
Therefore, you actually impair the function of your long acting agent.
12:20-12:23
So it fails on two counts of physicochemical reality.
12:24-12:24
So you just
12:24-12:24
don't do it.
12:24-12:32
Now, there's a great paper that I'm going to link in the show notes that explores pharmacological and clinical implications of local anaesthetic mixtures.
12:32-12:34
And it's a narrative review and it's really good.
12:34-12:36
So I would thoroughly recommend reading that.
12:36-12:38
but you might have heard about mixing bicarb in with things.
12:39-12:39
You know, you've got
12:39-12:40
that bum abscess,
12:41-12:46
it's grotty, it's angry, it's inflamed, the tissues are acidic around it, the local anesthetics just
12:46-12:50
barely work. Wouldn't it be dandy if we could make it more alkaline with bicarb?
12:50-12:51
And the answer is
12:51-12:51
yes
12:51-12:57
you can. So if you mix in bicarb you achieve a more alkaline environment and therefore improved
12:57-12:57
onset time.
12:57-12:58
Again we
12:58-13:03
hit another barrier here though in that unfortunately bupivacaine, levobupivacaine
13:03-13:09
and ropivacaine have a tendency to precipitate when mixed with bicarb, so that's kind of in the
13:09-13:14
bin. However, lidocaine behaves and therefore that is an option, mix your lidocaine with bupivacaine.
13:15-13:23
It's approximately 1 ml of 8.4% sodium bicarb per 10 ml of local anaesthetic. Some sites use a
13:23-13:31
lidocaine bicarb mix for rapid onset of surgical anaesthesia via the epidural route in sections.
13:31-13:36
You bang it in and it works real quick. So there are a number of other additives that are used,
13:36-13:41
were used, could be used more in the future. Noting that you could mix clonidine in,
13:41-13:46
that's compatible with lidocaine and bupivacaine. The evidence is mixed, but it may improve block
13:47-13:52
duration. And again, dexmedetomidine, this is technically not compatible, but seemingly folks
13:52-13:58
do use it. And that appears to extend block effect in some studies so far. Ketamine has been used,
13:58-14:04
and it has a positive effect. Ketamine in itself has some local anaesthetic-like sodium channel
14:04-14:08
blocking properties. However, there is some evidence that it is injurious to those nerves
14:08-14:14
and the CNS. There's a degree of evidence that says that magnesium prolongs regional anaesthetic
14:14-14:19
blockade. You just need to make sure you don't accidentally put a humongous amount intrathecally.
14:19-14:24
Apparently that's happened. Steroids. There's mounting evidence that either co-administered
14:24-14:29
steroids or IV high-dose steroids prolongs the effect of your local anesthetic on nerve,
14:30-14:35
although it may actually be that intravenous steroids work just as well. With a lower risk
14:35-14:38
factor, you're putting less next to very important nerve structures, aren't
14:38-14:38
you? Now, we know
14:38-14:39
that
14:39-14:42
opioids seem to improve the quality of neuraxial
14:42-14:43
anesthesia. I don't know
14:43-14:45
about regional anesthesia
14:45-14:49
and if you stick some fentanyl in someone's interscalene, whether or not that has any value.
14:49-14:54
Obviously, these nerves have opiate receptors, but I wonder if anyone knows that, please
14:54-15:01
drop me an email. So we've dipped quite deep into pharmacodynamics there before we've even got to
15:01-15:04
side effects. These drugs do have a side effect profile, chiefly
15:04-15:06
ones arising
15:06-15:07
from toxicity,
15:07-15:12
so we know they're toxic. Bupificane tends to favour the cardiovascular system, binding to
15:12-15:19
myocardial proteins and blocking cardiac sodium channels. This impairs the phase zero of the
15:19-15:24
cardiac action potential, and we're going to touch on that in a second, but also can drop your
15:24-15:29
peripheral vascular resistance or your systemic vascular resistance, as well as dropping your
15:29-15:34
contractility and being arrhythmogenic. From a neuro perspective, we have sodium channels in
15:34-15:34
our
15:34-15:35
brains,
15:35-15:39
unsurprisingly, everyone. You get a spectrum of effect here depending on how much
15:40-15:45
agent has been absorbed and delivered to the brain. So these could come on very quickly if
15:45-15:50
you've accidentally squirted some into a vein and over a prolonged period of time if you've
15:50-15:57
inadvertently overdosed someone in a highly vascular bit of tissue. So early signs, patients get some
15:58-16:04
slightly excitatory effects. They get sensory disturbances like tinnitus, altered taste sensation,
16:04-16:11
metal taste in mouth, circumoral tingling. They can then progress on to seizure activity and coma.
16:11-16:16
Now you could perhaps make an argument that if someone's in a coma due to local anaesthetics,
16:16-16:21
then maybe they're going to not breathe very much. It's not really quite a side effect in some ways.
16:22-16:27
And as I understand, there are no real quoted GI, renal, metabolic or
16:27-16:28
endocrine
16:28-16:29
side effects of
16:29-16:32
local anaesthetics that you're going to be asked about in the exam. It's all about the toxicity.
16:32-16:38
And we touched on the action potentials of nerves. I just want to quickly differentiate the action
16:38-16:44
potentials you see in myocardium because this is something that interminably flummoxed me because
16:44-16:45
it all sounds exactly the same and it's
16:45-16:46
probably going to sound
16:46-16:47
exactly the same
16:47-16:48
to you but
16:48-16:48
consider
16:48-16:49
it cognitive
16:49-16:49
priming.
16:49-16:54
So there are actually five phases of the cardiac action potential compared to
16:54-17:00
a standard nerve with four. You have a phase zero and then a one, two, three and a four. Now phase
17:00-17:08
zero is the initial depolarization, that uptick. You get sodium shifting in and potassium being
17:08-17:09
able to shift
17:09-17:09
out.
17:09-17:14
There's phase one and this is a very small uptick at the top of this. If you
17:14-17:19
imagine that initial depolarization phase almost overshoots slightly. Phase one
17:19-17:20
happens and
17:20-17:20
there's
17:20-17:28
a slight rebound repolarization, i.e. a drop in the positivity of that cell, only slightly, and this
17:28-17:33
is due to briefly opened potassium channels, letting some potassium in. Then you have phase two.
17:34-17:39
This is the phase that you don't see in other neuronal action potentials, and it is the plateau
17:39-17:45
phase. This is facilitated by calcium channels, and these are L-type calcium channels. I don't know
17:45-17:52
if the L stands for long, but they open, they let calcium into the cell. This calcium was obviously
17:52-17:58
quite useful for sarcoplasmic reticulum to contract, but calcium influx provides a prolonged
17:58-18:00
period of positive cell
18:00-18:01
membrane compared
18:01-18:02
to good old-fashioned
18:02-18:04
nerve. Phase three, so
18:04-18:05
this is our
18:05-18:11
dip back towards electronegativity. Phase three is repolarisation. Calcium channels that have been
18:11-18:15
open close. Potassium channels wide open
18:15-18:15
here,
18:15-18:18
allowing shift of potassium out of the cell,
18:19-18:23
dropping it back towards electronegativity. And we get phase four, this is the resting state,
18:23-18:28
which is confusing really, because I would say that the resting state should be like first thing
18:28-18:34
but who knows anyway phase four resting state negative 96 millivolts and this is facilitated
18:35-18:38
by those potassium channels being open and a loss
18:38-18:39
of whatever
18:39-18:41
sodium and calcium channels remain
18:41-18:41
trying to
18:41-18:43
be open they're gone so
18:43-18:48
five phases 0 1 2 3 4 2 is the plateau phase that's where you're
18:48-18:52
getting all that calcium ingress courtesy of our l-type calcium channels
18:52-18:53
let's
18:53-18:53
remember that these
18:53-19:00
L-type calcium channels are a drug target, folks. That's where your dihydropyridine and non-dihydropyridines
19:00-19:06
come into play. Right, so quite a bit of talking thus far, but let's just touch on the pharmacokinetics
19:06-19:12
of these drugs. Remember, pharmacokinetics is absorption, distribution, metabolism, and elimination.
19:12-19:13
Add me.
19:13-19:14
I mentioned earlier that the absorption
19:14-19:15
behaviour,
19:15-19:17
the pivacaine, depends on where it is
19:17-19:22
injected and the vascularity of that site. So the range from most absorption to least absorption,
19:23-19:28
we say intercostal most, then cordial, then epidural, and then brachial plexus, and then
19:28-19:34
subcutaneous administration. There is a linear dose response relationship between peak plasma
19:34-19:40
concentration you will see and the amount of drug you've put in. Vasoconstrictors in the world of
19:40-19:46
bupivacaine do not influence this terribly much because bupivacaine has a local vasodilatory
19:47-19:52
effect, which is bothersome. It's probably that the surgeons stick adrenaline in to make themselves
19:52-19:56
feel better and actually it probably doesn't change very much. This bears out in reality because we
19:56-20:01
know it doesn't change how long the drug lasts for because the bubificane causes dilation which
20:01-20:01
means
20:01-20:01
there's
20:01-20:06
clearance from that site. That same dilation is not altered by administering adrenaline. The
20:07-20:11
time it lasts is the same therefore who really knows. But if it makes them happy it doesn't matter
20:11-20:16
although you might see a little bit of that beta 1 beta 2 response that you get by administering
20:16-20:21
adrenaline into subcutaneous tissues and you might get a bit of hypotension and then hypotension.
20:21-20:28
very interesting. So distribution. Its pKa as mentioned above is 8.1. So at physiological pH
20:28-20:35
you have 15% unionized. It is 95% protein bound which is mega and in plasma it is mostly bound
20:36-20:38
to alpha-1 acid glycoprotein.
20:38-20:39
It has a volume
20:39-20:42
of distribution of 21 to 103 liters but I don't
20:42-20:48
really think it is terribly relevant for this drug and it also binds to albumin. Metabolism. How does
20:48-20:54
how does the body get rid of it? So bupivacaine undergoes N-dealkylation, remember that's a phase
20:54-21:01
two metabolism liver thing, into pipey coloxylide. I don't think you need to know that, but it is
21:01-21:06
inactive. So it gets through the liver, phase two metabolism, N-dealkylation, inactive metabolite.
21:07-21:13
Clearance of 0.47 litres per minute and the elimination half-life after intravenous
21:13-21:19
administration is 0.3 to 0.6 hours, i.e. 20 to 40 minutes. So it does get out reasonably quickly.
21:19-21:24
Other things of note, remember that patients can be allergic to local anaesthetic agents,
21:24-21:30
although classically more likely to be allergic to ester local anaesthetic agents than amide local
21:30-21:36
anaesthetic agents. And interestingly, some vets administered up to 8 milligrams per kilo of
21:36-21:43
bupivacaine when they were trying to do interscalene blocks on ducts, and none of the ducts died
21:43-21:48
However, we need to think that maybe it's quite hard to inject into the brachial plexus of a
21:49-21:53
mallard duck. And maybe if they're squirting bupivacaine into a tendon or other fairly
21:54-21:58
avascular structures, the odds are that it couldn't absorb quick enough to cause harm.
21:58-22:01
Not that I'm recommending that as a dose, but I thought that was an interesting side
22:02-22:06
and reflects how easy it is to get very lost on the internet reading about things.
22:06-22:07
So just to
22:07-22:08
close out
22:08-22:10
the show, guys, and I hope you've managed to get here thus far,
22:10-22:16
Levo-bupivacaine, otherwise known as chirocaine, and chiro because it's all about chiral molecules
22:16-22:22
and enantiomers, which we're going to touch on later. Levo-bupivacaine is the S enantiomer of the
22:22-22:29
racemic-bupivacaine mixture. Why are we interested in levo-bupivacaine? Well, it does seem to cause
22:29-22:34
a bit less of a motor block, interestingly. It seems to yield sensory blocks more so,
22:35-22:40
especially in lower doses. There is a notion that it is slightly less potent than its racemic
22:40-22:45
mixture which might make you think that if you were to take the other enantiomate R-bupivacaine
22:45-22:50
you might have a more potent local anesthetic agent. So why on earth did they bother trying to
22:50-22:55
divvy this out and use one half of bupivacaine? And the answer is levobupivacaine is less
22:56-23:01
cardiotoxic. If you were to pick which toxicity you would like, CNS toxicity, i.e. your brain
23:02-23:03
turns off until you clear the local
23:03-23:04
out,
23:04-23:07
is probably less harmful than ventricular fibrillation.
23:08-23:12
One, you just need to wait. The other one, you might not be able to undo. Hence why
23:13-23:19
levobupivacaine is more readily favoured. What is the dose? So the max dose is generally quoted as
23:19-23:27
150 milligrams in one go with a total of 400 milligrams over 24 hours. So this would work out
23:27-23:36
at about 30 mils of 0.5% in an appropriately sized adult or about 200 mils of 0.5% over 24 hours.
23:36-23:47
In some literature, the max dose of levobupificane is quoted as 2.5 milligrams per kilo instead of the 2 milligrams per kilo of standard bupificane.
23:47-23:49
This is why it tends to be favoured.
23:50-23:51
It really confused me when I first started.
23:51-23:55
Which one's levo? Which one's bupificane? Which one's kyrocane? Which one's marcane?
23:55-23:57
Kyrocane is levobupificane.
23:57-23:59
Standard bupificane is marcane.
23:59-24:04
Heavy marcane is when it's mixed with glucose for intrathecal administration so it sinks
24:04-24:04
down.
24:04-24:07
Oh and that's your lot folks, you've listened to the end, you've done brilliantly well. That was
24:07-24:12
bupivacaine with a touch on cardiac action potential, neuronal action potential and additives
24:13-24:17
you could mix in and their approximate likelihood of having clinical benefit. I think the jury is
24:18-24:23
approximately out on most of it, there's no robust consistent, everyone does one thing,
24:23-24:28
I think I'd be tempted to say that steroids probably help and most other things might help
24:28-24:34
but it's less clear at this point in time. Thanks for listening guys, I hope you've
24:34-24:39
found it useful but if you found it awful do let me know. Please like and subscribe, register with
24:39-24:43
whichever podcast platform you find yourself using and leave a comment if you think I need to square
24:44-24:48
something away. I just want to make sure that you guys know that every day you are getting better at
24:48-24:52
this. There is a bucket of content to try and consume and it is like drinking from a fire hose.
24:53-24:57
Take it day by day, don't overcook yourself, don't freak out and keep studying.
Leave a Reply